Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood pressure
MedTech
Labcorp unveils first-trimester blood test for preeclampsia risk
The test is designed to be performed between 11 and 14 weeks into pregnancy and delivers a risk score for developing the condition before 34 weeks.
Conor Hale
May 21, 2024 2:30pm
Samsung plots noninvasive glucose sensor devices: Bloomberg
Jan 23, 2024 12:45pm
Roche's bet pays off as Alnylam hypertension med hits in phase 2
Sep 7, 2023 8:55am
After bankruptcy, Rockley Photonics hones blood pressure laser
Aug 10, 2023 10:45am
Mineralys upsizes IPO to raise $192M for race with AstraZeneca
Feb 10, 2023 9:10am
AstraZeneca inks $1.8B CinCor takeover for blood pressure drug
Jan 9, 2023 7:20am
